Effect of rapid plasma volume expansion during anesthesia induction on haemodynamics and oxygen balance in patients undergoing gastrointestinal surgery

International Journal of Medical Sciences

Volumn 10, Issue 4, 2013, Pages 355-361

  Lin, Fu Qing ^a   Li, Cheng ^a   Zhang, Li Jun ^b   Fu, Shu Kun ^a   Chen, Guo qiang ^a   Yang, Xiao Hu ^a   Zhu, Chun Yan ^a   Li, Quan ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b No187 Hospital of PLA   (China)

Author keywords

Gastrointestinal surgery; General anaethesia; Haemodynamics; Hydroxyethyl starch; Oxygen balance

Indexed keywords

ATRACURIUM BESILATE; HEMOGLOBIN; HETASTARCH; OXYGEN;

ADULT; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTERIAL PRESSURE; ARTICLE; BISPECTRAL INDEX; BLOOD GAS ANALYSIS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SURGERY; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; OXYGEN EXTRACTION FRACTION; OXYGEN SUPPLY; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; VENOUS BLOOD;

GASTROINTESTINAL SURGERY.; GENERAL ANAETHESIA; HAEMODYNAMICS; HYDROXYETHYL STARCH; OXYGEN BALANCE;

ADULT; ANESTHESIA; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; GASTROINTESTINAL TRACT; HEMODYNAMICS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PLASMA SUBSTITUTES; PLASMA VOLUME;

EID: 84874776152     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5294     Document Type: Article

References (45)

1. Lehmann GB, Asskali F, Boll M, Burmeister MA, Marx1 G, Hilgers R, Förster H. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth. 2007; 98: 635-644.
2. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology. 2007; 106: 1120-1127.
3. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996; 84: 732-747.
4. Waitzinger J, Bepperling F, Pabst G, Opitz J, Fackelmayer A, Boldt J. Effect of new hydroxyethyl starch (HES) specification [6% HES (130/0.4)] on blood and plasma volumes after bleeding in 12 healthy male volunteers. Clin Drug Invest. 1999; 17: 119-125.
5. Waitzinger J, Bepperling F, Pabst G, Opitz J, Müller M, Francois Baron J. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Invest. 1998; 16: 151-160.
6. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D. 2003; 4: 149-157.
7. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D. 2003; 4: 331-338.
8. de Jonge E, Levi M, Buller HR, Berends F, Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med. 2001; 27: 1825-1829.
9. Türkan H, Ural AU, Beyan C, Yalcin A. Effects of hydroxyethyl starch on blood coagulation profile. Eur J Anaesthesiol. 1999; 16:156-159.
10. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000; 47:1207-1215.
11. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg. 2001; 92: 855-862.
12. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: A randomised, double-blind study. Drugs R D. 2004; 5:1-9.
13. Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Anesth Analg. 2000; 90:274-279.
14. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6%HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg. 2001; 92:565-571.
15. Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology. 2003; 99:42-47.
16. Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med. 2011; 37:1725-1737.
17. Ertmer C, Wulf H, Van Aken H, Friederich P, Mahl C, Bepperling F, Westphal M, Gogarten W. Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients. Minerva Med. 2012; 103: 111-122.
18. James MF, Latoo MY, Mythen MG, Mutch M, Michaelis C, Roche AM, Burdett E. Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers. Anaesthesia. 2004; 59: 738-742.
19. Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth. 2003; 91: 196-202.
20. Kasper SM, Strömich A, Kampe S, Radbruch L. Evaluation of a new hydroxyethyl starch solution (HES 130/0.4) in patients undergoing preoperative autologous blood donation. J Clin Anesth. 2001; 13: 486-490.
21. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg. 2003; 96: 1453-1459.
22. Alan D, Kaye, Alan W. Fluid and electrolyte physiology. In: Miller RD, ed. Anesthesia; 5th ed. San Francisco: Churchill Livingstone. 2000: 1605.
23. Baraka AS, Taha SK., Ghabach MB, Sibaii AA, Nader AM. Intravascuoar administration of polymerized gelatin versus isotonic saline for prevention of spinal-induced hypotension. Anesth Analg. 1994; 78: 301-305.
24. Edwards JD, Nightingale P, Wilking RG, Faragher EB. Hemodynamic and oxygen transport response to modified fluid gelatin in critically ill patients. Crit Care Med. 1989; 17: 996-998.
25. Manecke GR. Edwards FloTrac sensor and Vigileo monitor: easy, accurate, reliable cardiac output assessment using the arterial pulse wave. Expert Rev Med Devices. 2005; 2: 523-527.
26. Button D, Weibel L, Reuthebuch O, Genoni M, Zollinger A, Hofer CK. Clinical evaluation of the FloTrac/Vigileo system and two established continuous cardiac output monitoring devices in patients undergoing cardiac surgery. Br J Anaesth. 2007; 99: 329-336.
27. Cannesson M, Attof Y, Rosamel P, Joseph P, Bastien O, Lehot JJ. Comparison of FloTrac cardiac output monitoring system in patients undergoing coronary artery bypass grafting with pulmonary artery cardiac output measurements. Eur J Anaesthesiol. 2007; 24: 832-839.
28. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: a review of indices used in intensive care. Intensive Care Med. 2003; 29: 352-360.
29. Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest. 2002; 121: 2000-2008.
30. Reuse C, Vincent JL, Pinsky MR. Measurements of right ventricular volumes during fluid challenge. Chest. 1990; 98: 1450-1454.
31. Feissel M, Michard F, Mangin I, Ruyer O, Faller JP, Teboul JL. Respiratory changes in aortic blood velocity as an indicator of fluid responsiveness in ventilated patients with septic shock. Chest. 2001; 119: 867-873.
32. Berkenstadt H, Margalit N, Hadani M, Friedman Z, Segal E, Villa Y, Perel A. Stroke volume variation as a predictor of fluid responsiveness I patients undergoing brain surgery. Anesth Analg. 2001; 92: 984-989.
33. Reuter DA, Felbinger TW, Schmidt C, Kilger E, Goedje O, Lamm P, Goetz AE. Stroke volume variations for assessment of cardiac responsiveness to volume loading in mechanically ventilated patients after cardiac surgery. Intensive Care Med. 2002; 28: 392-398.
34. Reuter DA, Kirchner A, Felbinger TW, Weis FC, Kilger E, Lamm P, Goetz AE. Usefulness of left ventricular stroke volume variation to assess fluid responsive-ness in patients with reduced cardiac function. Crit Care Med. 2003; 31: 1399-1404.
35. Marx G, Cope T, McCrossan L, Swaraj S, Cowan C, Mostafa SM, Wenstone R, Leuwer M. Assessing fluid responsiveness by stroke volume variation in mechanically ventilated patients with severe sepsis. Eur J Anaesthesiol. 2004; 21: 132-138.
36. Liu SQ, Qiu HB, Yang Y, Li JQ, Shen JF. Assessment of stroke volume variation and intrathoracic blood volume index on the responsiveness to volume loading in mechanically ventilated canine with hemorrhagic shock. Zhonghua Wai Ke Za Zhi. 2006; 44: 1216-1219.
37. Hofer CK, Müller SM, Furrer L, Klaghofer R, Genoni M, Zollinger A. Stroke volume and pulse pressure variation for prediction of fluid responsiveness in patients undergoing off-pump coronary artery bypass grafting. Chest. 2005; 128: 848-854.
38. Rex S, Brose S, Metzelder S, Hüneke R, Schälte G, Autschbach R, Rossaint R, Buhre W. Prediction of fluid responsiveness in patients during cardiac surgery. Br J Anaesth. 2004; 93: 782-788.
39. Su BC, Tsai YF, Cheng CW, Yu HP, Yang MW, Lee WC, Lin CC. Stroke volume variation derived by arterial pulse contour analysis is a good indicator for preload estimation during liver transplantation. Transplant Proc. 2012; 44: 429-432.
40. Khwannimit B, Bhurayanontachai R. Prediction of fluid responsiveness in septic shock patients: comparing stroke volume variation by FloTrac/Vigileo and automated pulse pressure variation. Eur J Anaesthesiol. 2012; 29: 64-69.
41. Zhang Z, Lu B, Sheng X, Jin N. Accuracy of stroke volume variation in predicting fluid responsiveness: a systematic review and meta-analysis. J Anesth. 2011; 25: 904-916.
42. Woessner R, Grauer MT, Dieterich HJ, Bepperling F, Baus D, Kahles T, Georgi S, Bianchi O, Morgenthaler M, Treib J. Influence of a long-term, high dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in pa tients with acute ischemic stroke. Pathophysiol Haemost Thromb. 2003; 33: 121-126.
43. Schou H, Perez de Sa V, Laresson A. Central and mixed venous blood oxygen correlate well during acute normovolemic hemodilution in anesthetized pigs. Acta Anaesthesiol Seam. 1998; 4: 172-177.
44. Ladakis C, Myrianthefs P, Karabinis A, Karatzas G, Dosios T, Fildissis G, Gogas J, Baltopoulos G. Central venous and mixed venous oxygen saturation in critically ill patients. Respiration. 2001; 68: 279-285.
45. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg. 2001; 93: 405-409.